Idexx Laboratories (IDXX) Short term Debt (2009 - 2026)

Idexx Laboratories' Short term Debt history runs 18 years deep, the most recent figure standing at $150.0 million for Q1 2026.

• In Q1 2026, Short term Debt fell 53.05% year-over-year to $150.0 million; the TTM figure through Mar 2026 stood at $150.0 million (down 53.05% YoY), while the FY2025 annual figure was $398.0 million, up 137.21% from the prior year.
• Short term Debt for Q1 2026 stood at $150.0 million, down from $398.0 million in the prior quarter.
• The five-year high for Short term Debt was $633.0 million in Q3 2022, with the low at $150.0 million in Q3 2023.
• The 5-year median for Short term Debt is $250.0 million (2022), against an average of $312.3 million.
• The sharpest annual moves came in 2022 and 2023: Short term Debt surged 744.11% in 2022, then plunged 76.3% in 2023.
• Idexx Laboratories' Short term Debt stood at $250.0 million in 2022, then changed by 0.0% to $250.0 million in 2023, then slumped by 32.89% to $167.8 million in 2024, then jumped by 137.21% to $398.0 million in 2025, then slumped by 62.31% to $150.0 million in 2026.
• Business Quant data shows IDXX's Short term Debt at $150.0 million in Q1 2026, $398.0 million in Q4 2025, and $150.0 million in Q3 2025.